Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Erythrocytosis Prospective Cohort Study (EVEREST): Diagnosis, Management and Longitudinal Outcomes in Patients with Elevated Hemoglobin

NCT06785870 is registered in ClinicalTrials.gov with Cyrus Hsia as lead sponsor.

NCT NCT06785870
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06785870 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Erythrocytosis Prospective Cohort Study (EVEREST): Diagnosis, Management and Longitudinal Outcomes in Patients with Elevated Hemoglobin
Lead sponsor
Cyrus Hsia
Phase
Observational
Overall status
Not yet recruiting
Start date
February 1, 2025
Completion date
December 31, 2030
Enrollment
1,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

erythrocytosis, polycythemia, polycythemia secondary, polycythemia vera, polycythemia vera (pv), polycythemia vera, post-polycythemic myelofibrosis phase, polycythemia, primary, polycythemia; familial